From 2010 to 2023, GLP-1RAs and SGLT2 inhibitors saw rising prescriptions in type 1 diabetes, particularly for patients with obesity and cardiorenal risks.
UPMC Researchers Create Algorithm that Accurately Identifies High-Risk Surgical Patients
What You Should Know: Researchers and physicians at the University of Pittsburgh and UPMC used machine learning to create and deploy an accurate and flexible model for
July 10, 2023